open access

Vol 12, No 2 (2015)
Review paper
Get Citation

A place of aripiprazole in the treatment of schizophrenia group psychosis

Justyna Pełka-Wysiecka
Psychiatria 2015;12(2):55-61.

open access

Vol 12, No 2 (2015)
Prace poglądowe - nadesłane

Abstract

Schizophrenia is a serious mental disease requiring systematic pharmacological treatment. During last years it has been mostly treated with second generation of antipsychotic drugs and one of their representative — aripiprazole. This substance belongs to well tolerated, effective and safe agents in respect of metabolic and endocrine side effects. It may be administered as well as treatment of disease onset or by chronic patients. It is succesfully used as mono- or politherapy.

Abstract

Schizophrenia is a serious mental disease requiring systematic pharmacological treatment. During last years it has been mostly treated with second generation of antipsychotic drugs and one of their representative — aripiprazole. This substance belongs to well tolerated, effective and safe agents in respect of metabolic and endocrine side effects. It may be administered as well as treatment of disease onset or by chronic patients. It is succesfully used as mono- or politherapy.

Get Citation

Keywords

schizophrenia, aripiprazole, pharmacotherapy, switching of therapy, efficacy, side effects

About this article
Title

A place of aripiprazole in the treatment of schizophrenia group psychosis

Journal

Psychiatria (Psychiatry)

Issue

Vol 12, No 2 (2015)

Article type

Review paper

Pages

55-61

Bibliographic record

Psychiatria 2015;12(2):55-61.

Keywords

schizophrenia
aripiprazole
pharmacotherapy
switching of therapy
efficacy
side effects

Authors

Justyna Pełka-Wysiecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl